CCI4EU - Clinical trials and clinical research
This course is the second of 10 online training courses organised within the project to help countries develop an effective comprehensive infrastructure and widen the reach of this grant. The topic of this online course is: Clinical Trials and Clinical Research.
The aim is to discover how to build a successful and sustainable clinical research programme.
The first part of this course was made available on this website from 16 September 2024.
The second part of this online course was held live on 15 October 2024 via this webpage. The entire course was recorded and is now available as on-demand material.
To access the on-demand materials (after the live streaming), participants must register to the course, login to the e-ESO platform and click on the play buttons inside the course programme.
Certificate of attendance
Organising secretariat
Francesca Marangoni: fmarangoni@eso.net
Sonia Bulgarelli: sbulgarelli@eso.net
PART 1: How to make clinical research balanced between academia and pharma-sponsored?
| 16/09/2024 |
Academic studies/commercial, which is the right proportion? - common cancers
| Expert: | Richard Baird, UK |
Academic studies/commercial, which is the right proportion? - rare cancers
| Expert: | Silvia Stacchiotti, IT |
How multidisciplinary tasks forces contribute to foster translational research
| Expert: | Alejandro Piris, ES |
PART 2: Clinical Research as a Fundamental Pillar of CCIs: innovation, quality control, sustainability, outcomes and PROs
| 16/09/2024 |
How do you build your network? Euracan ERN as a model
| Expert: | Jean-Yves Blay, FR |
How to initiate and conduct clinical trials in Europe? Protarget Study as a model trial for precision oncology
| Expert: | Ulrik Lassen, DK |
How to manage the usage of medical data? Step forward to data federation based on IDEA4RC project
| Expert: | Annalisa Trama, IT |
PART 3: How to navigate the threats for clinical research in Europe?
| 16/09/2024 |
How to harmonise the processes for assessment and supervision of clinical trials throughout the EU? The pros and cons of the EU CTR
| Expert: | Scott Greenfeder, US |
How does IVDR affect clinical research in Europe?
| Expert: | Dario Trapani, IT |
How do you conduct/finance academic studies with a molecular pre-screening programme and drug supply?
| Expert: | Carlos Lopez, ES |
LIVE STREAMING
| 15/10/2024 |
Introduction and welcome
| 15/10/2024 |
| Chairs: | Iwona Lugowska, PL - Josep Tabernero, ES |
PART 1: How to make clinical research balanced between academia and pharma-sponsored?
| 15/10/2024 |
Summary
| Expert: | Josep Tabernero, ES |
Discussion
| Experts: | Jean-Yves Blay, FR - Rachel Giles, NL - Josep Tabernero, ES - Winette van der Graaf, NL |
| Moderator: | Iwona Lugowska, PL |
PART 2: Clinical Research as a Fundamental Pillar of CCIs: innovation, quality control, sustainability, outcomes and PROs
| 15/10/2024 |
Summary
| Expert: | Iwona Lugowska, PL |
Discussion
| Experts: | Elena Garralda, ES - Rachel Giles, NL - Iwona Lugowska, PL - Mef Nilbert, SE |
| Moderator: | Josep Tabernero, ES |
PART 3: How to navigate the threats for clinical research in Europe?
| 15/10/2024 |
Summary
| Expert: | Josep Tabernero, ES |
Discussion
| Experts: | Rachel Giles, NL - Francesco Pignatti, NL - Josep Tabernero, ES - Ana Zanoletty, NL - Jan-Willem van de Loo, BE |
| Moderator: | Iwona Lugowska, PL |
PART 4: Example cases
| 15/10/2024 |
Western Europe experience
| Expert: | Maud Kamal, FR |
Eastern Europe experience
| Expert: | Piotr Rutkowski, PL |
Take home message and closing remarks
| 15/10/2024 |
| Chairs: | Iwona Lugowska, PL - Josep Tabernero, ES |
/attachment.e-eso.net/48/734756ea-08d3-44e7-aa0a-59f316ed5fc9.jpeg)
Academic Consultant in Experimental Cancer Therapeutics, Cancer Research UK Cambridge Centre, University of Cambridge, Cambridge, United Kingdom
/attachment.e-eso.net/48/36141816-e67f-4b8a-93e4-b304860b4e26.jpg)
Université Claude Bernard Lyon & Centre Léon Bérard, Lyon, France
/attachment.e-eso.net/48/dd28eefc-24d7-482f-ad87-25d85c820e43.jpg)
Codirector VHIO Clinical Research Program, Vall d’Hebron Institute of Oncology, Barcelona, Spain
/attachment.e-eso.net/48/5831dc76-e7f9-4767-b6c8-d808dfbf1f85.jpg)
President, VHL Europa, Amsterdam, The Netherlands
/attachment.e-eso.net/48/253ca6a0-2209-452f-9ee0-3a71bee7fa95.jpg)
VP Head Oncology Regulatory Strategy Nucleus, Bayer USA, Whippany NJ, USA
/attachment.e-eso.net/48/6eba7a57-398c-4035-a1ae-508057075552.png)
Executive Director, Institut Hospitalo Universitaire PRISM - Gustave Roussy Cancer Campus, Paris, France
/attachment.e-eso.net/48/a1227774-53ae-4dd4-8f80-aa370205c759.jpg)
Head of Oncology Department, Rigshospitalet, Copenhagen, Denmark
/attachment.e-eso.net/48/642466db-46a2-425a-b5a9-150728d95f68.jpg)
Vall d’Hebron Institute of Oncology, Barcelona, Spain
/attachment.e-eso.net/48/dbb0bde9-d1dc-4a73-8b60-3f34edb9e908.jpg)
Head of International Cooperation, MSC National Research Institute of Oncology, Warsaw, Poland
/attachment.e-eso.net/48/7258c991-355c-42fd-8fe2-d59316d6fe71.jpg)
Lund University, Lund, Sweden
/attachment.e-eso.net/48/b21e06ef-0d69-4ad8-9068-609daf50fdfd.jpeg)
Scientific Adviser for Oncology, European Medicines Agency, Amsterdam, The Netherlands
/attachment.e-eso.net/48/f63cef27-2e09-4b86-9ed1-805f90fbb5fd.jpg)
Head of the Scientific Coordination/Management Area, Vall d’Hebron Institute of Oncology, Barcelona, Spain
/attachment.e-eso.net/48/d2c9dee7-cb2c-4ad1-a20b-807d27134e60.jpg)
Plenipotentiary of Head Director for National Oncological Strategy and Clinical Trials, Maria Sklodowska-Curie National Research Institute of Oncology, Warsaw, Poland
/attachment.e-eso.net/48/7c9f815d-019e-4c5c-8719-a0d5e6a0f26a.jpg)
National Cancer Institute - IRCCS Foundation, Milan, Italy
/attachment.e-eso.net/48/ffad2184-f6ce-4691-8b6e-bd3c5c18db97.jpg)
Vall d'Hebron University Hospital, Barcelona, Spain
/attachment.e-eso.net/48/462.jpg)
National Cancer Institute - IRCCS Foundation, Milan, Italy
/attachment.e-eso.net/48/2021041404172573.png)
European Institute of Oncology, Milan, Italy
/attachment.e-eso.net/48/cbe140ea-c1cf-4ace-bfb6-5b87fc5ab42a.jpg)
Cancer Theme Lead, Senior Expert Cancer Research and Innovation, European Commission, Brussels, Belgium
/attachment.e-eso.net/48/c70e693b-db4f-464d-8217-31c01573c15c.png)
Head of Medical Oncology Department, Antoni van Leeuwenhoek Hospital-Netherlands Cancer Institute; Erasmus Medical Center, Amsterdam, The Netherlands
/attachment.e-eso.net/48/86b8b6c4-8bf6-47c2-ab21-97a084ba2f60.jpg)
Head of Clinical Trials Transformation, European Medicines Agency, Amsterdam, The Netherlands
This course is part of
Funded by
